论文信息 - ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference

[1] G. Lip,et al. Antithrombotic therapy for atrial fibrillation , 2002, BMJ : British Medical Journal.

[2] G. Lip,et al. Paroxysmal atrial fibrillation. , 2001, QJM : monthly journal of the Association of Physicians.

[3] P. Vardas,et al. Sinus Pacemaker Function after Cardioversion of Chronic Atrial Fibrillation: Is Sinus Node Remodeling Related with Recurrence? , 2001, Journal of cardiovascular electrophysiology.

[4] J. Halperin,et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. , 2001, The New England journal of medicine.

[5] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[6] R. Grimm,et al. Potential clinical efficacy and cost benefit of a transesophageal echocardiography-guided low-molecular-weight heparin (enoxaparin) approach to antithrombotic therapy in patients undergoing immediate cardioversion from atrial fibrillation. , 2001, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[7] Z. Yuan,et al. Risk of stroke in patients with atrial flutter. , 2001, The American journal of cardiology.

[8] A. Waldo,et al. Efficacy and safety of moricizine in the maintenance of sinus rhythm in patients with recurrent atrial fibrillation. , 2001, The American journal of cardiology.

[9] E. Ohman,et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. , 2001, Chest.

[10] M. Allessie,et al. Mapping of atrial fibrillation. , 2001, Annali dell'Istituto superiore di sanita.

[11] I. V. Van Gelder,et al. Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm and amiodarone. , 2000, The American journal of cardiology.

[12] S. Hohnloser,et al. Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial , 2000, The Lancet.

[13] H. Wellens. Pulmonary vein ablation in atrial fibrillation: hype or hope? , 2000, Circulation.

[14] R. Beyth,et al. A Multicomponent Intervention To Prevent Major Bleeding Complications in Older Patients Receiving Warfarin , 2000, Annals of Internal Medicine.

[15] M. Brodsky,et al. Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter: The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study , 2000, Circulation.

[16] P. Vardas,et al. Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study , 2000, Heart.

[17] B. Maron,et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. , 2000, Circulation.

[18] C. Lau,et al. Effects of biatrial pacing in prevention of postoperative atrial fibrillation after coronary artery bypass surgery. , 2000, Circulation.

[19] R. Page,et al. Initial energy for elective external cardioversion of persistent atrial fibrillation. , 2000, The American journal of cardiology.

[20] I. V. Van Gelder,et al. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. , 2000, European heart journal.

[21] J. Halperin,et al. Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation. , 2000, The American journal of medicine.

[22] K. Stangl,et al. Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study. , 2000, Journal of the American College of Cardiology.

[23] A. Natale,et al. Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. , 2000, Journal of the American College of Cardiology.

[24] P. Vardas,et al. Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study. , 2000, Chest.

[25] T Fahey,et al. The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis. , 2000, BMJ : British Medical Journal.

[26] E. Prystowsky,et al. Management of atrial fibrillation: therapeutic options and clinical decisions. , 2000, The American journal of cardiology.

[27] G. Naccarelli,et al. Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy. , 2000, The American journal of cardiology.

[28] H. Crijns,et al. Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter. , 2000, The American journal of cardiology.

[29] Takenoriyamaguchi. Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation , 2000 .

[30] J Clémenty,et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. , 2000, Circulation.

[31] P. Tchou,et al. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. , 2000, Circulation.

[32] G. Kay,et al. Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis. , 2000, Circulation.

[33] K A Schulman,et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. , 2000, Circulation.

[34] L. Zaputović,et al. Unmasking Effect of Propafenone on the Concealed Form of the Brugada Phenomenon , 2000, Pacing and clinical electrophysiology : PACE.

[35] M. Niemelä,et al. Effectiveness of amiodarone as a single oral dose for recent-onset atrial fibrillation. , 2000, The American journal of cardiology.

[36] H. White,et al. Serum troponins T and I after elective cardioversion. , 2000, European heart journal.

[37] Shih‐Ann Chen,et al. Radiofrequency Catheter Ablation of Atrial Fibrillation Initiated by Pulmonary Vein Ectopic Beats , 2000, Journal of cardiovascular electrophysiology.

[38] N. Ishikawa,et al. Is there a place for the late cardioversion of atrial fibrillation? A long-term follow-up study of patients with post-thyrotoxic atrial fibrillation. , 2000, European heart journal.

[39] J. Rothrock,et al. Cardioembolic vs. Noncardioembolic Strokes in Atrial Fibrillation: Frequency and Effect of Antithrombotic Agents in the Stroke Prevention in Atrial Fibrillation Studies , 2000, Cerebrovascular Diseases.

[40] D. Shah,et al. Catheter Ablation of Chronic Atrial Fibrillation Targeting the Reinitiating Triggers , 2000, Journal of cardiovascular electrophysiology.

[41] A. Brett. Amiodarone to Prevent Recurrence of Atrial Fibrillation , 2000 .

[42] Inger,et al. AN ANALYSIS OF THE LOWEST EFFECTIVE INTENSITY OF PROPHYLACTIC ANTICOAGULATION FOR PATIENTS WITH NONRHEUMATIC ATRIAL FIBRILLATION , 2000 .

[43] M. Glanz,et al. The Sharer , 2000, Annals of Internal Medicine.

[44] S. Lévy,et al. Classification system of atrial fibrillation. , 2000, Current opinion in cardiology.

[45] Marlene R. Miller,et al. The evidence regarding the drugs used for ventricular rate control. , 2000, The Journal of family practice.

[46] J. Halperin,et al. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. , 2000, Journal of the American College of Cardiology.

[47] J. Halperin,et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). , 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[48] J. Halperin,et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). , 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[49] B K Khandheria,et al. Echocardiographic assessment of the left atrial appendage. , 1999, Journal of the American College of Cardiology.

[50] G. Botto,et al. External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements , 1999, Heart.

[51] S. Nattel,et al. The T-type Ca(2+) channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs. , 1999, Circulation.

[52] I. V. Van Gelder,et al. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation. , 1999, The American journal of cardiology.

[53] R. Hart,et al. Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention , 1999, Annals of Internal Medicine.

[54] C. Tai,et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. , 1999, Circulation.

[55] A. Natale,et al. Usefulness of ibutilide in facilitating successful external cardioversion of refractory atrial fibrillation. , 1999, The American journal of cardiology.

[56] M. Di leo,et al. Transesophageal echocardiographic evidence of more pronounced left atrial stunning after chemical (propafenone) rather than electrical attempts at cardioversion from atrial fibrillation. , 1999, The American journal of cardiology.

[57] A. Natale,et al. AV Node Ablation and Pacemaker Implantation After Withdrawal of Effective Rate‐Control Medications for Chronic Atrial Fibrillation: Effect on Quality of Life and Exercise Performance , 1999, Pacing and clinical electrophysiology : PACE.

[58] J. Knottnerus,et al. Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin , 1999, BMJ.

[59] O. Benavente,et al. Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation , 1999, Annals of Internal Medicine.

[60] J. Gorter,et al. Major bleeding during anticoagulation after cerebral ischemia , 1999, Neurology.

[61] I. V. Van Gelder,et al. Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation , 1999, Heart.

[62] A. Camm,et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. , 1999, The New England journal of medicine.

[63] S Chierchia,et al. Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. , 1999, Circulation.

[64] M. Wijffels. The Natural History of Atrial Fibrillation: , 1999, Journal of cardiovascular electrophysiology.

[65] M. Gasparini,et al. Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion. , 1999, Journal of the American College of Cardiology.

[66] S. Lansman,et al. Oral d,lsotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study☆ , 1999 .

[67] T. Guarnieri,et al. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial. , 1999, Journal of the American College of Cardiology.

[68] C. Tai,et al. Effects of radiofrequency catheter ablation on quality of life in patients with atrial flutter. , 1999, The American journal of cardiology.

[69] R. Steeds,et al. An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation , 1999, Heart.

[70] P. Kowey,et al. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. , 1999, Circulation.

[71] L. Køber,et al. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. , 1999, Circulation.

[72] S Nattel,et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. , 1999, Circulation.

[73] M. Rosenqvist,et al. Effect of intravenous magnesium on heart rate and heart rate variability in patients with chronic atrial fibrillation. , 1999, The American journal of cardiology.

[74] V. Barriales,et al. Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group. , 1999, American heart journal.

[75] P. Petersen,et al. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation. , 1999, Archives of internal medicine.

[76] O. Benavente,et al. Increased Risk of Intracranial Hemorrhage when Aspirin Is Combined with Warfarin: A Meta-Analysis and Hypothesis , 1999, Cerebrovascular Diseases.

[77] F. Morady,et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. , 1999, The New England journal of medicine.

[78] S. Lévy,et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. , 1999, Circulation.

[79] F. Morady,et al. Short-term effect of atrial fibrillation on atrial contractile function in humans. , 1999, Circulation.

[80] J. McMurray,et al. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation. , 1999, Circulation.

[81] A. Camm,et al. Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation. , 1999, Circulation.

[82] B. Nørgaard,et al. Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled trial , 1999 .

[83] J Melo,et al. Surgery for atrial fibrillation using radiofrequency catheter ablation: assessment of results at one year. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[84] R McBride,et al. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. , 1999, Stroke.

[85] S. Connolly,et al. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. , 1999, Circulation.

[86] D. Armstrong,et al. Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation , 1999, BMJ.

[87] M. Cotrufo,et al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. , 1999, Journal of the American College of Cardiology.

[88] J. Halperin,et al. Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications. , 1999, Stroke.

[89] R. Holder,et al. Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation: effects of pacing mode and mode-switch algorithm. , 1999, Circulation.

[90] H. Calkins,et al. A new system for catheter ablation of atrial fibrillation. , 1999, The American journal of cardiology.

[91] E. Prystowsky,et al. Sotalol: An important new antiarrhythmic. , 1999, American Heart Journal.

[92] J. Halperin,et al. Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. , 1999, American heart journal.

[93] N. Saoudi,et al. Radiofrequency catheter ablation of common atrial flutter: significance of palpitations and quality-of-life evaluation in patients with proven isthmus block. , 1999, Circulation.

[94] Bramahn . Singh,et al. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. , 1999, Journal of the American College of Cardiology.

[95] S. Hohnloser,et al. Heart Rate Variability to Assess Changes in Cardiac Vagal Modulation Prior to the Onset of Paroxysmal Atrial Fibrillation in Patients With and Without Structural Heart Disease , 1999 .

[96] R. Califf,et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[97] J. Boineau,et al. Radial approach: a new concept in surgical treatment for atrial fibrillation I. Concept, anatomic and physiologic bases and development of a procedure. , 1999, The Annals of thoracic surgery.

[98] P. Vardas,et al. Efficacy of amiodarone for the termination of persistent atrial fibrillation. , 1999, The American journal of cardiology.

[99] S. Lansman,et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study. , 1999, Journal of the American College of Cardiology.

[100] B. Nørgaard,et al. Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group. , 1999, American heart journal.

[101] P. Podrid. Prevention of postoperative atrial fibrillation: what is the best approach? , 1999, Journal of the American College of Cardiology.

[102] P. Schweitzer,et al. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis. , 1998, The American journal of cardiology.

[103] P C Deedwania,et al. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. , 1998, Circulation.

[104] S. Saksena,et al. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention. , 1998, Journal of the American College of Cardiology.

[105] E. Antman,et al. Guidelines for the management of patients with valvular heart disease: executive summary , 1998, Circulation.

[106] E. Ohman,et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. , 1998, Chest.

[107] D. Shah,et al. Long‐Term Follow‐Up After Right Atrial Radiofrequency Catheter Treatment of Paroxysmal Atrial Fibrillation , 1998, Pacing and clinical electrophysiology : PACE.

[108] B. Winters,et al. &ggr;‐Adrenergic Blockade Accelerates Conversion of Postoperative Supraventricular Tachyarrhythmias , 1998, Anesthesiology.

[109] M. Noble,et al. Myocardial contractility is not constant during spontaneous atrial fibrillation in patients. , 1998, Circulation.

[110] S. Connolly,et al. The Canadian Registry of Atrial Fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillation. , 1998, The American journal of cardiology.

[111] R. Falk,et al. Etiology and complications of atrial fibrillation: insights from pathology studies. , 1998, The American journal of cardiology.

[112] Rose Anne Kenny,et al. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community , 1998, The Lancet.

[113] A. Skanes,et al. Spatiotemporal periodicity during atrial fibrillation in the isolated sheep heart. , 1998, Circulation.

[114] Patients with atrial fibrillation at low risk of stroke. , 1998, JAMA.

[115] M. Brignole,et al. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. , 1998, Circulation.

[116] J Clémenty,et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.

[117] M. Scheinman,et al. Electroanatomical Mapping and Ablation of the Substrate Supporting Intraatrial Reentrant Tachycardia after Palliation for Complex Congenital Heart Disease , 1998, Pacing and clinical electrophysiology : PACE.

[118] S. Lévy,et al. Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. , 1998, European heart journal.

[119] M A Waclawiw,et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. , 1998, Journal of the American College of Cardiology.

[120] B. Mcgovern,et al. Antiarrhythmic drug therapy in pregnancy and lactation. , 1998, The American journal of cardiology.

[121] G. Nante,et al. Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation. , 1998, The American journal of cardiology.

[122] S. Hohnloser,et al. Atrial fibrillation--maintaining sinus rhythm versus ventricular rate control: the PIAF trial. Pharmacological Intervention in Atrial Fibrillation. , 1998, Journal of cardiovascular electrophysiology.

[123] H. Mond,et al. Left atrial "stunning" following radiofrequency catheter ablation of chronic atrial flutter. , 1998, Journal of the American College of Cardiology.

[124] S. Lowson,et al. Atrial Fibrillation and Thromboembolism , 1998, Anesthesia and analgesia.

[125] K. Stangl,et al. Superiority of ibutilide (a new class III agent) overdl-sotalol in converting atrial flutter and atrial fibrillation , 1998, Heart.

[126] H. Lambert,et al. Effect of Electrode Length on Atrial Defibrillation Thresholds , 1998, Journal of cardiovascular electrophysiology.

[127] F. Paganelli,et al. Antibodies Against Myosin in Sera of Patients with Idiopathic Paroxysmal Atrial Fibrillation , 1998, Journal of cardiovascular electrophysiology.

[128] J. Halperin,et al. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. , 1998, Journal of the American College of Cardiology.

[129] M. Gammage,et al. Atrioventricular nodal ablation and implantation of mode switching dual chamber pacemakers: effective treatment for drug refractory paroxysmal atrial fibrillation , 1998, Heart.

[130] G. Lupi,et al. Left atrial appendage function assessed by transesophageal echocardiography before and on the day after elective cardioversion for nonvalvular atrial fibrillation. , 1998, The American journal of cardiology.

[131] T. Ganiats,et al. Comparison of Quality of Well-Being scale and NYHA functional status classification in patients with atrial fibrillation. New York Heart Association. , 1998, American heart journal.

[132] P. Kowey,et al. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. , 1998, Journal of the American College of Cardiology.

[133] K. Harjai,et al. Mechanical dysfunction of the left atrium and the left atrial appendage following cardioversion of atrial fibrillation and its relation to total electrical energy used for cardioversion. , 1998, The American journal of cardiology.

[134] V. Boyko,et al. Significance of Paroxysmal Atrial Fibrillation Complicating Acute Myocardial Infarction in the Thrombolytic Era , 1998 .

[135] K. Ellenbogen,et al. Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. , 1998, The American journal of cardiology.

[136] R. Hart,et al. Sister Mary Joseph's Nodule , 1998, Annals of Internal Medicine.

[137] Biatrial high density mapping of electrically induced atrial fibrillation in humans , 1998 .

[138] H. Wellens,et al. Immediate Reinitiation of Atrial Fibrillation Following Internal Atrial Defibrillation , 1998, Journal of cardiovascular electrophysiology.

[139] H. Crijns,et al. Cardioversion of atrial fibrillation in the setting of mild to moderate heart failure. , 1998, International journal of cardiology.

[140] The impact of adjusting for post-test referral bias on apparent sensitivity and specificity of SPECT myocardial perfusion imaging in men and women , 1998 .

[141] Effect of mitral regurgitation on coagulation activity in atrial fibrillation. , 1998, The American journal of cardiology.

[142] A. Capucci. Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm. , 1998, American Journal of Cardiology.

[143] L. Toivonen,et al. Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. , 1998, Journal of cardiovascular pharmacology.

[144] J Haaksma,et al. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? , 1998, Journal of the American College of Cardiology.

[145] Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. , 1998, Archives of internal medicine.

[146] R. Cheung. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. , 1998, JAMA.

[147] Transesophageal Echocardiographic Correlates of Thromboembolism in High-Risk Patients with Nonvalvular Atrial Fibrillation , 1998, Annals of Internal Medicine.

[148] J. Camm,et al. Classification of atrial fibrillation. , 1998, Pacing and clinical electrophysiology : PACE.

[149] F. Morady,et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery , 1997 .

[150] K. Ellenbogen,et al. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy. , 1997, Circulation.

[151] L. Shaw,et al. Cost effectiveness of inpatient initiation of antiarrhythmic therapy for supraventricular tachycardias. , 1997, The American journal of cardiology.

[152] E. Topol. Textbook of Cardiovascular Medicine , 1997 .

[153] M R Franz,et al. Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. , 1997, Journal of the American College of Cardiology.

[154] M. Allessie,et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. , 1997, Circulation.

[155] L. Thuesen,et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome , 1997, The Lancet.

[156] M. Brignole,et al. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. , 1997, Circulation.

[157] L H Kuller,et al. Incidence of and risk factors for atrial fibrillation in older adults. , 1997, Circulation.

[158] S Nattel,et al. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. , 1997, Circulation research.

[159] F. Martin,et al. Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study. , 1997, European heart journal.

[160] G. Kay,et al. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. , 1997, Journal of the American College of Cardiology.

[161] S. Saksena,et al. Internal Atrial Defibrillation: Effect on Sinus and Atrioventricular Nodal Function and Implanted Cardiac Pacemakers , 1997, Pacing and clinical electrophysiology : PACE.

[162] M. Russo,et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.

[163] R. Califf,et al. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. , 1997, Journal of the American College of Cardiology.

[164] M. Kinoshita,et al. Incidence of ischemic strokes in hypertrophic cardiomyopathy is markedly increased if complicated by atrial fibrillation. , 1997, Japanese circulation journal.

[165] S. Lévy,et al. Low-energy cardioversion of spontaneous atrial fibrillation. Immediate and long-term results. , 1997, Circulation.

[166] C. January,et al. Adverse effects of low dose amiodarone: a meta-analysis. , 1997, Journal of the American College of Cardiology.

[167] M. Woodward,et al. EPIDEMIOLOGY OF COAGULATION FACTORS, INHIBITORS AND ACTIVATION MARKERS: THE THIRD GLASGOW MONICA SURVEY I. ILLUSTRATIVE REFERENCE RANGES BY AGE, SEX AND HORMONE USE , 1997, British journal of haematology.

[168] R. Tracy,et al. Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. , 1997, Stroke.

[169] C. Upshaw,et al. Hemodynamic changes after cardioversion of chronic atrial fibrillation. , 1997, Archives of internal medicine.

[170] SergioCoccheri,et al. Indobufen Versus Warfarin in the Secondary Prevention of Major Vascular Events in Nonrheumatic Atrial Fibrillation , 1997 .

[171] G. Lip. Hypercoagulability and haemodynamic abnormalities in atrial fibrillation , 2022 .

[172] K. Berkin,et al. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. , 1997, Heart.

[173] B. Drew,et al. Risk of thromboembolism in chronic atrial flutter. , 1997, The American journal of cardiology.

[174] A. Pezzano,et al. Activation of the hemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillation. , 1997, Circulation.

[175] A. Capucci,et al. Oral Propafenone To Convert Recent-Onset Atrial Fibrillation in Patients with and without Underlying Heart Disease , 1997, Annals of Internal Medicine.

[176] A. Torbicki,et al. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct‐current cardioversion , 1997, Clinical cardiology.

[177] M. Allessie,et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria. , 1997, Circulation.

[178] L. Jordaens,et al. Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo. , 1997, European heart journal.

[179] J. L. Huang,et al. Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation. , 1997, The American journal of cardiology.

[180] R. Wanless,et al. Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias. , 1997, American heart journal.

[181] J. Brugada,et al. Identification of a genetic locus for familial atrial fibrillation. , 1997, The New England journal of medicine.

[182] K. Ellenbogen,et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. , 1997, Journal of the American College of Cardiology.

[183] S. Lévy,et al. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. , 1997, Journal of the American College of Cardiology.

[184] S. Lévy,et al. Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation. , 1997, The American journal of cardiology.

[185] S. Connolly,et al. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT , 1997, The Lancet.

[186] A. Camm,et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT , 1997, The Lancet.

[187] J. Brugada,et al. Atrial fibrillation induced by atrioventricular nodal reentrant tachycardia. , 1997, The American journal of cardiology.

[188] P. Grayburn,et al. Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients undergoing cardioversion of atrial flutter. A prospective study using transesophageal echocardiography. , 1997, Circulation.

[189] R. Stroobandt,et al. Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators. , 1997, The American journal of cardiology.

[190] J Clémenty,et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. , 1997, Circulation.

[191] E. Prystowsky. Atrioventricular Node Reentry: Physiology and Radiofrequency Ablation , 1997, Pacing and clinical electrophysiology : PACE.

[192] M. Chung,et al. Cardioversion Guided by Transesophageal Echocardiography: The ACUTE Pilot Study: A Randomized, Controlled Trial , 1997, Annals of Internal Medicine.

[193] R. Falk,et al. Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. , 1997, Journal of the American College of Cardiology.

[194] L. Tsai,et al. Prevalence and clinical significance of left atrial thrombus in nonrheumatic atrial fibrillation. , 1997, International journal of cardiology.

[195] A L Waldo,et al. Simultaneous multisite mapping studies during induced atrial fibrillation in the sterile pericarditis model. Insights into the mechanism of its maintenance. , 1997, Circulation.

[196] A. Capucci,et al. Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens. , 1997, International journal of cardiology.

[197] D. Sherman,et al. Atrial fibrillation and stroke. , 1997, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[198] The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators. , 1997, Archives of internal medicine.

[199] Atrial fibrillation follow-up investigation of rhythm management -- the AFFIRM study design. The Planning and Steering Committees of the AFFIRM study for the NHLBI AFFIRM investigators. , 1997, The American journal of cardiology.

[200] Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group. , 1997, European heart journal.

[201] S. Amitani,et al. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. , 1997, Journal of the American College of Cardiology.

[202] I C van Gelder,et al. UvA-DARE ( Digital Academic Repository ) Efficacy , safety , and determinants of conversion of atrial fibrillation and flutter with oral amiodarone , 1997 .

[203] H. Crijns,et al. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. , 1996, Archives of internal medicine.

[204] D P Zipes,et al. Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs. Electrophysiological remodeling. , 1996, Circulation.

[205] R. Gray,et al. Incomplete reentry and epicardial breakthrough patterns during atrial fibrillation in the sheep heart. , 1996, Circulation.

[206] M. Gold,et al. Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery. , 1996, The American journal of cardiology.

[207] Intravenous amiodarone in treatment of recent-onset atrial fibrillation. , 1996 .

[208] Mark A. Wood,et al. Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation , 1996 .

[209] D. Mehta,et al. Thromboembolism following cardioversion of "common" atrial flutter. Risk factors and limitations of transesophageal echocardiography. , 1996, Chest.

[210] C. Schmitt,et al. Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. , 1996, Journal of the American College of Cardiology.

[211] G. Kay,et al. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. , 1996, Circulation.

[212] B. Gage,et al. The Effect of Stroke and Stroke Prophylaxis With Aspirin or Warfarin on Quality of Life , 1996 .

[213] W. J. Hamilton,et al. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial , 1996, The Lancet.

[214] Y. Nakamura,et al. Predictors of ischemic stroke in non-rheumatic atrial fibrillation. , 1996, International journal of cardiology.

[215] L. Kuller,et al. Correlates of thrombin markers in an elderly cohort free of clinical cardiovascular disease. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[216] M. Santini,et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. , 1996, Journal of the American College of Cardiology.

[217] D. Singer,et al. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. , 1996, The New England journal of medicine.

[218] F. Morady,et al. Transesophageal echocardiographic evaluation of left atrial appendage function and spontaneous contrast formation after chemical or electrical cardioversion of atrial fibrillation. , 1996, The American journal of cardiology.

[219] M. Russell. The long QT syndromes , 1996 .

[220] G. Lip,et al. Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. , 1996, Circulation.

[221] L. Cohn,et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. , 1996, Circulation.

[222] R. Harper,et al. Determinants of increased regional left atrial coagulation activity in patients with mitral stenosis. , 1996, Circulation.

[223] P. Sager,et al. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study. , 1996, Journal of the American College of Cardiology.

[224] S. Fihn,et al. The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin , 1996, Annals of Internal Medicine.

[225] U. Elkayam. Anticoagulation in pregnant women with prosthetic heart valves: a double jeopardy. , 1996, Journal of the American College of Cardiology.

[226] R. Schmieder,et al. Reversal of Left Ventricular Hypertrophy in Essential Hypertension: A Meta-analysis of Randomized Double-blind Studies , 1996 .

[227] A. Proclemer,et al. Intravenous propafenone in paroxysmal atrial fibrillation: A randomized, placebo‐controlled, double‐blind, multicenter clinical trial , 1996 .

[228] G. Lip,et al. Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis. , 1996, American heart journal.

[229] J. Soler‐Soler,et al. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. , 1996, Journal of the American College of Cardiology.

[230] K. Ellenbogen,et al. Conversion of atrial flutter by ibutilide is associated with increased atrial cycle length variability. , 1996, Journal of the American College of Cardiology.

[231] V. Fuster,et al. Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. , 1996, Circulation.

[232] N. Wheeldon. Coronary heart disease and atrial fibrillation , 1996, BMJ.

[233] C. Tai,et al. Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double‐blind, randomized trial , 1996, Journal of internal medicine.

[234] David C. Anderson,et al. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. , 1996, Archives of internal medicine.

[235] E. Prystowsky,et al. Effect of continuous vagal enhancement on concealed conduction and refractoriness within the atrioventricular node. , 1996, The American journal of cardiology.

[236] A. Sheikhzadeh,et al. Detection of a Hypercoagulable State in Nonvalvular Atrial Fibrillation and the Effect of Anticoagulant Therapy , 1996, Thrombosis and Haemostasis.

[237] P. Coumel,et al. Drug therapy for prevention of atrial fibrillation. , 1996, The American journal of cardiology.

[238] S. Hohnloser,et al. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group. , 1996, The American journal of cardiology.

[239] N. Kerin,et al. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation. , 1996, Archives of internal medicine.

[240] K. Ellenbogen,et al. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. , 1996, Circulation.

[241] G. Klein,et al. Investigation of the patient with atrial fibrillation. , 1996, The Canadian journal of cardiology.

[242] T E Cuddy,et al. Atrial fibrillation and atrial flutter. , 1996, The Canadian journal of cardiology.

[243] P. Oettgen,et al. Prevalence of residual left atrial thrombi among patients with acute thromboembolism and newly recognized atrial fibrillation. , 1995, Archives of internal medicine.

[244] R. Sung,et al. Determination of ventricular vulnerable period and ventricular fibrillation threshold by use of T-wave shocks in patients undergoing implantation of cardioverter/defibrillators. , 1995, Circulation.

[245] M. Bamoshmoosh,et al. Effectiveness of intravenous propafenone for conversion of recent‐onset atrial fibrillation: A placebo‐controlled study , 1995, Clinical cardiology.

[246] Mark A. Hlatky,et al. Guidelines for the Evaluation and Management of Heart Failure Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure) , 1995 .

[247] M. Allessie,et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.

[248] S. Hohnloser,et al. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. , 1995, Journal of the American College of Cardiology.

[249] R. Page,et al. Treatment of arrhythmias during pregnancy. , 1995, American heart journal.

[250] M. Huttunen,et al. Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the Sotalol-Digoxin-Quinidine Trial). , 1995, The American journal of cardiology.

[251] J. Boineau,et al. Modification of the maze procedure for atrial flutter and atrial fibrillation. I. Rationale and surgical results. , 1995, The Journal of thoracic and cardiovascular surgery.

[252] J L Cox,et al. Modification of the maze procedure for atrial flutter and atrial fibrillation. II. Surgical technique of the maze III procedure. , 1995, The Journal of thoracic and cardiovascular surgery.

[253] A. Capucci,et al. Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration. , 1995, Chest.

[254] W. Manning,et al. Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. , 1995, Circulation.

[255] P C Deedwania,et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[256] P. Koudstaal. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. , 1995, The New England journal of medicine.

[257] W. Stevenson,et al. Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. , 1995, The American journal of cardiology.

[258] J. Thomas,et al. Left atrial appendage "stunning" after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography. , 1995, American heart journal.

[259] H. Matsuoka,et al. Mechanism of atrial fibrillation and increased incidence of thromboembolism in patients with hypertrophic cardiomyopathy. , 1995, Japanese circulation journal.

[260] J. Hirsh,et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. , 1995, The New England journal of medicine.

[261] R. Baroffio,et al. A Randomised Study Comparing Digoxin and Propafenone in the Treatment of Recent Onset Atrial Fibrillation , 1995 .

[262] A. Camm,et al. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. , 1995, Journal of the American College of Cardiology.

[263] A. Sheikhzadeh,et al. Relation of left atrial appendage function to the duration and reversibility of nonvalvular atrial fibrillation. , 1995, The American journal of cardiology.

[264] P. Oettgen,et al. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. , 1995, Journal of the American College of Cardiology.

[265] F A Mathewson,et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. , 1995, The American journal of medicine.

[266] D P Zipes,et al. Radiofrequency catheter ablation of the atria reduces inducibility and duration of atrial fibrillation in dogs. , 1995, Circulation.

[267] R. Falk,et al. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group. , 1995, American heart journal.

[268] S. Cobbe,et al. Chemical cardioversion of atrial fibrillation with intravenous dofetilide. , 1995, International journal of cardiology.

[269] M. Chang,et al. Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study. , 1995, European heart journal.

[270] B. Hockings,et al. Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. , 1995, The American journal of cardiology.

[271] G. Koren,et al. Pregnancy outcome after gestational exposure to amiodarone in Canada. , 1995, American journal of obstetrics and gynecology.

[272] W. Manning,et al. Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm. , 1995, The American journal of cardiology.

[273] A Laupacis,et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. , 1995, Archives of internal medicine.

[274] Douglas L. Jones,et al. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. , 1995, Circulation.

[275] R. Pistelli,et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. , 1995, The American journal of medicine.

[276] N. Ammash,et al. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographics tudy , 1995 .

[277] Therapy for atrial fibrillation: control of the ventricular response and prevention of recurrence. , 1995, Coronary artery disease.

[278] J. Alpert,et al. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. , 1992, Chest.

[279] N. Ammash,et al. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. , 1995, Journal of the American College of Cardiology.

[280] T. Binder,et al. Diurnal variation of ventricular response to atrial fibrillation in patients with advanced heart failure. , 1995, American heart journal.

[281] R. Cebul,et al. Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials. , 1995, American heart journal.

[282] A. Efthymiadis,et al. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias. , 1995, Acta cardiologica.

[283] S. Lévy,et al. Paroxysmal atrial fibrillation: a need for classification. , 1995, Journal of cardiovascular electrophysiology.

[284] L. Pearce. Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: The stroke prevention in atrial fibrillation study. , 1995, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[285] U. Ikeda,et al. Coagulation activity is increased in the left atrium of patients with mitral stenosis. , 1995, Journal of the American College of Cardiology.

[286] L. Thuesen,et al. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome , 1994, The Lancet.

[287] R. Josephson. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. , 1994, Circulation.

[288] J. Roelandt,et al. Transthoracic echo/Doppler in the identification of patients with chronic non-valvular atrial fibrillation at risk for thromboembolic events. , 1994, European heart journal.

[289] P. Kligfield,et al. Variability of the ventricular response in atrial fibrillation and prognosis in chronic nonischemic mitral regurgitation. , 1994, The American journal of cardiology.

[290] G. Ferrari,et al. Regular Ventricular Rhythms Before Conversion of Recent Onset Atrial Fibrillation to Sinus Rhythm , 1994, Pacing and clinical electrophysiology : PACE.

[291] G. Feld,et al. Control of rapid ventricular response by radiofrequency catheter modification of the atrioventricular node in patients with medically refractory atrial fibrillation. , 1994, Circulation.

[292] J. Blumenthal,et al. Quality-of-life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia. , 1994, The American journal of cardiology.

[293] M. Niebauer,et al. Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. , 1994, The New England journal of medicine.

[294] D. Leung,et al. Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. , 1994, Journal of the American College of Cardiology.

[295] J. Gardin,et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). , 1994, The American journal of cardiology.

[296] R. M. Payne,et al. Management of Arrhythmias in Patients with Severe Lung Disease , 1994 .

[297] B. Rubal,et al. Effect of magnesium sulfate on ventricular rate control in atrial fibrillation. , 1994, Annals of emergency medicine.

[298] W. Lien,et al. Significant mitral regurgitation is protective against left atrial spontaneous echo contrast formation, but not against systemic embolism. , 1994, Chest.

[299] Carotid stenosis in patients with atrial fibrillation , 1994 .

[300] W. Manning,et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. , 1994, Journal of the American College of Cardiology.

[301] E. Hylek,et al. Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin , 1994, Annals of Internal Medicine.

[302] S. Bertil Olsson,et al. Atrial Fibrillation: Mechanisms and Therapeutic Strategies , 1994 .

[303] D. Fatkin,et al. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. , 1994, Circulation.

[304] C. Schmitt,et al. Initial Experience with Intracardiac Atrial Defibrillation in Patients with Chronic Atrial Fibrillation , 1994, Pacing and clinical electrophysiology : PACE.

[305] J Haaksma,et al. Analysis of vagal effects on ventricular rhythm in patients with atrial fibrillation. , 1994, Clinical science.

[306] G. Klein,et al. Risk of Sudden Arrhythmic Death in the Wolff‐Parkinson‐White Syndrome: Current Perspectives , 1994, Pacing and clinical electrophysiology : PACE.

[307] J. Hochman,et al. Prognostic significance of left ventricular aneurysm in the Cardiac Arrhythmia Suppression Trial (CAST) population. , 1994, American heart journal.

[308] R. Ganam,et al. Clinical course of recent-onset atrial fibrillation treated with oral propafenone. , 1994, Chest.

[309] M. Allessie,et al. High-density mapping of electrically induced atrial fibrillation in humans. , 1994, Circulation.

[310] Stroke Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study , 1994, The Lancet.

[311] D. Levy,et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.

[312] D. Fatkin,et al. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. , 1994, Journal of the American College of Cardiology.

[313] L. Lai,et al. Clinical implications of left atrial appendage flow patterns in nonrheumatic atrial fibrillation. , 1994, Chest.

[314] W. Daniel,et al. Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk. , 1994, Journal of the American College of Cardiology.

[315] A. Capucci,et al. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. , 1994, International journal of cardiology.

[316] G. Ewy. The optimal technique for electrical cardioversion of atrial fibrillation , 1994, Clinical cardiology.

[317] D. Fatkin,et al. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications. , 1994, Journal of the American College of Cardiology.

[318] M. Ovadia,et al. Human experience with amiodarone in the embryonic period. , 1994, The American journal of cardiology.

[319] J. Rothrock,et al. Carotid stenosis in patients with atrial fibrillation. Prevalence, risk factors, and relationship to stroke in the Stroke Prevention in Atrial Fibrillation Study. , 1994, Archives of internal medicine.

[320] Y. Tseng,et al. Clinical implications and factors related to left atrial spontaneous echo contrast in chronic nonvalvular atrial fibrillation. , 1994, Cardiology.

[321] Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. , 1994, Archives of internal medicine.

[322] [Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation--conversion and 12-month follow-up--a randomized comparison]. , 1994, Zeitschrift fur Kardiologie.

[323] G. Ayers,et al. Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation. , 1994, Circulation.

[324] Eaft Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993, The Lancet.

[325] H. Crijns,et al. Changes in left and right atrial size after cardioversion of atrial fibrillation: role of mitral valve disease. , 1993, Journal of the American College of Cardiology.

[326] R. Grimm,et al. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. , 1993, Journal of the American College of Cardiology.

[327] L. Creswell,et al. Hazards of postoperative atrial arrhythmias , 1993 .

[328] J. Cox. A perspective of postoperative atrial fibrillation in cardiac operations. , 1993, The Annals of thoracic surgery.

[329] A. Zbrozek,et al. Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter. , 1993, The American journal of cardiology.

[330] H. Crijns,et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. , 1993, The American journal of cardiology.

[331] A. Madrid,et al. Comparison of flecainide and procainamide in cardioversion of atrial fibrillation. , 1993, European heart journal.

[332] R. Poole,et al. Left Atrial Spontaneous Echo Contrast Is Highly Associated With Previous Stroke in Patients With Atrial Fibrillation or Mitral Stenosis , 1993, Stroke.

[333] J. Cohn,et al. The Influence of Atrial Fibrillation on Prognosis in Mild to Moderate Heart Failure The V‐HeFT Studies , 1993, Circulation.

[334] M. Enriquez-Sarano,et al. Multiplane transesophageal echocardiography: image orientation, examination technique, anatomic correlations, and clinical applications. , 1993, Mayo Clinic proceedings.

[335] Oral clonidine for heart rate control in chronic atrial fibrillation , 1993, The Lancet.

[336] P. Brill-Edwards,et al. The use of an indwelling Teflon catheter for subcutaneous heparin administration during pregnancy. A randomized crossover study. , 1993, Archives of internal medicine.

[337] L. Poller,et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. , 1993, The New England journal of medicine.

[338] A. Stead,et al. Effects of age, race, sex, and smoking on prothrombin fragment 1.2 in a healthy population. , 1993, Clinical Chemistry.

[339] R. Ideker,et al. Internal Cardioversion of Atrial Fibrillation in Sheep , 1993, Circulation.

[340] H. Krumholz,et al. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. , 1993, The New England journal of medicine.

[341] J. Tijssen,et al. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. , 1993, The American journal of cardiology.

[342] E. Antman,et al. Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. , 1993, The American journal of cardiology.

[343] A. Harada,et al. Successful combined operation for mitral stenosis and atrial fibrillation. , 1993, The Annals of thoracic surgery.

[344] M. Kotler,et al. Significant mitral regurgitation is protective against left atrial spontaneous echo contrast and thrombus as assessed by transesophageal echocardiography. , 1993, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[345] K. Bailey,et al. A Population Study of the Natural History of Wolff‐Parkinson‐White Syndrome in Olmsted Count, Minnesota, 1953‐1989 , 1993, Circulation.

[346] W. Walsh,et al. Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation. , 1993, Journal of the American College of Cardiology.

[347] J. Rothrock,et al. Ischemic stroke in patients with atrial fibrillation , 1993, Neurology.

[348] Leandro Provinciali,et al. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .

[349] G. Schlierf,et al. Prophylaxis of embolic events in patients with atrial fibrillation using low molecular weight heparin. , 1993, Seminars in thrombosis and hemostasis.

[350] D. Zipes,et al. Canine left ventricular hypertrophy predisposes to ventricular tachycardia induction by phase 2 early afterdepolarizations after administration of BAY K 8644. , 1992, Journal of the American College of Cardiology.

[351] S M Nazarian,et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. , 1992, The New England journal of medicine.

[352] H. Calkins,et al. A Randomized Comparison of External and Internal Cardioversion of Chronic Atrial Fibrillation , 1992, Circulation.

[353] Jeffrey S. Ginsberg,et al. Use of antithrombotic agents during pregnancy. , 1992, Chest.

[354] I. Sand. Predictors of Thromboembolism in Atrial Fibrillation: I. Clinical Features of Patients at Risk , 1992, Annals of Internal Medicine.

[355] A. Constantinesco,et al. Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy. , 1992, European heart journal.

[356] P. dos Santos,et al. Flecainide acetate in the prevention of paroxysmal atrial fibrillation: a nine-month follow-up of more than 500 patients. , 1992, The American journal of cardiology.

[357] S. Hifumi,et al. Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation. , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[358] N Bom,et al. Multiplane transesophageal echocardiography: latest evolution in an imaging revolution. , 1992, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[359] A. Capucci,et al. Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. , 1992, The American journal of cardiology.

[360] D. Levy,et al. Predictors of Thromboembolism in Atrial Fibrillation , 1992, Annals of Internal Medicine.

[361] H. Crijns,et al. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. , 1992, JAMA.

[362] H C Smith,et al. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. , 1992, The American journal of cardiology.

[363] J M de Bakker,et al. Increased dispersion of "refractoriness" in patients with idiopathic paroxysmal atrial fibrillation. , 1992, Journal of the American College of Cardiology.

[364] E L Pritchett,et al. Management of atrial fibrillation. , 1992, The New England journal of medicine.

[365] S. Hohnloser,et al. Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: results of a comparative study and a 2-year follow-up. , 1992, Journal of the American College of Cardiology.

[366] R. Marinchak,et al. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. , 1992, The American journal of cardiology.

[367] F. Loop,et al. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. , 1992, Journal of the American College of Cardiology.

[368] E. M. Gold. Principles and Practice of Medical Therapy in Pregnancy , 1992 .

[369] P. Coumel. Neural aspects of paroxysmal atrial fibrillation , 1992 .

[370] U. Goldbourt,et al. Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction , 1992 .

[371] G. Guiraudon,et al. The Pathology of Drug Resistant Lone Atrial Fibrillation in Eleven Surgically Treated Patients , 1992 .

[372] E. Hjelms. Procainamide conversion of acute atrial fibrillation after open-heart surgery compared with digoxin treatment. , 1992, Scandinavian journal of thoracic and cardiovascular surgery.

[373] Predictors of Thromboembolism in Atrial Fibrillation: II. Echocardiographic Features of Patients at Risk , 1992, Annals of Internal Medicine.

[374] Predictors of Thromboembolism in Atrial Fibrillation: I. Clinical Features of Patients at Risk , 1992, Annals of Internal Medicine.

[375] Philip J. Podrid,et al. Atrial fibrillation : mechanisms and management , 1992 .

[376] E. Prystowsky,et al. Role of concealed and supernormal conductions during atrial fibrillation in the preexcitation syndrome. , 1991, The American journal of cardiology.

[377] J. Kluger,et al. Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation , 1991 .

[378] E. Antman,et al. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. , 1991, Circulation.

[379] S. Lévy,et al. Predictors of In‐Hospital Mortality After DC Catheter Ablation of Atrioventricular Junction: Results of a Prospective, International, Multicenter Study , 1991, Circulation.

[380] D M Mirvis,et al. A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study. , 1991, Journal of the American College of Cardiology.

[381] R. Kerber,et al. Ischemic cerebrovascular complications and risk factors in idiopathic hypertrophic subaortic stenosis. , 1991, Stroke.

[382] B. Marino,et al. Ventricular conduction defects and atrial fibrillation after coronary artery bypass grafting. Multivariate analysis of preoperative, intraoperative and postoperative variables. , 1991, European heart journal.

[383] M. Laakso,et al. The European Stroke Prevention Study , 1991, Neurology.

[384] M Gent,et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. , 1991, Journal of the American College of Cardiology.

[385] D. Singer,et al. Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study. , 1991, The American journal of medicine.

[386] P. Wolf,et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[387] Lippincott Williams Wilkins,et al. Stroke Prevention in Atrial Fibrillation Study: Final Results , 1991, Circulation.

[388] H. Crijns,et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. , 1991, The American journal of cardiology.

[389] J. Hirsh. Oral anticoagulant drugs. , 1991, The New England journal of medicine.

[390] R. Lazzara,et al. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. , 1991, The New England journal of medicine.

[391] E. Prystowsky,et al. Effect of continuous enhanced vagal tone on atrioventricular nodal and sinoatrial nodal function in humans. , 1991, Circulation research.

[392] A. Pietersen,et al. Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group. , 1991, The American journal of cardiology.

[393] P B Corr,et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. , 1991, The Journal of thoracic and cardiovascular surgery.

[394] J. Zatuchni. Atrial enlargement as a consequence of atrial fibrillation. , 1991, Circulation.

[395] P B Corr,et al. The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. , 1991, The Journal of thoracic and cardiovascular surgery.

[396] P. Coumel,et al. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. , 1991, European heart journal.

[397] G. Dobb,et al. Reversion of recent-onset atrial fibrillation to sinus rhythm by intravenous flecainide. , 1991, The American journal of cardiology.

[398] G. Fontana,et al. Amiodarone versus quinidine for conversion of recent onset atrial fibrillation to sinus rhythm , 1991 .

[399] A. Labovitz,et al. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. , 1991, Journal of the American College of Cardiology.

[400] I. V. Van Gelder,et al. Incidence and clinical significance of ST segment elevation after electrical cardioversion of atrial fibrillation and atrial flutter. , 1991, American heart journal.

[401] J. Kluger,et al. Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group. , 1991, American Journal of Cardiology.

[402] The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. , 1991, The New England journal of medicine.

[403] S. Juul-Möller,et al. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. , 1990 .

[404] K. Lie,et al. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. , 1990, Journal of the American College of Cardiology.

[405] G. Feld. Atrial fibrillation. Is there a safe and highly effective pharmacological treatment? , 1990, Circulation.

[406] Bernard Rosner,et al. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. , 1990, The New England journal of medicine.

[407] M. Lesser. Safety and efficacy of in-office cardioversion for treatment of supraventricular arrhythmias. , 1990, The American journal of cardiology.

[408] G. Klein,et al. Prognostic value of electrophysiology testing in asymptomatic patients with Wolff-Parkinson-White pattern. , 1990, Circulation.

[409] J. Coulehan,et al. Cardiac manifestations of Churg-Strauss syndrome: report of a case and review of the literature. , 1990, American heart journal.

[410] M. Allessie,et al. Ventricular response during irregular atrial pacing and atrial fibrillation. , 1990, The American journal of physiology.

[411] E. Antman,et al. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. , 1990, Circulation.

[412] P. Harris,et al. The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. , 1990, The Journal of thoracic and cardiovascular surgery.

[413] A. Weyman,et al. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. , 1990, Circulation.

[414] L. Wilkins. European Stroke Prevention Study. ESPS Group. , 1990, Stroke.

[415] J. Bogousslavsky,et al. Pathogenesis of anterior circulation stroke in patients with nonvalvular atrial fibrillation , 1990, Neurology.

[416] E. Prystowsky,et al. Occurrence of Atrial Fibrillation in Patients With Paroxysmal Supraventricular Tachycardia Due to Atrioventricular Nodal Reentry , 1990, Pacing and clinical electrophysiology : PACE.

[417] J. Alpert,et al. Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspective. , 1990, American heart journal.

[418] M. Frenneaux,et al. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. , 1990, Journal of the American College of Cardiology.

[419] W. M. Smith,et al. Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillation after cardiac operations. , 1990, The Journal of thoracic and cardiovascular surgery.

[420] J. Rawles,et al. Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin. , 1990, British heart journal.

[421] M. Horvat,et al. Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm. , 1990, The American journal of cardiology.

[422] J. Rawles,et al. What is meant by a "controlled" ventricular rate in atrial fibrillation? , 1990, British heart journal.

[423] E. Antman,et al. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs. , 1990, Journal of the American College of Cardiology.

[424] A. Miller,et al. Coadministration of flecainide acetate and sotalol during pregnancy: lack of teratogenic effects, passage across the placenta, and excretion in human breast milk. , 1990, American heart journal.

[425] Low dose warfarin reduces risk of stroke in nonrheumatic atrial fibrillation , 1990 .

[426] C. Giglioli,et al. Propafenone versus amiodarone in field treatment of primary atrial tachydysrhythmias. , 1990, The Journal of emergency medicine.

[427] J. Seeger,et al. Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation. , 1990, Archives of internal medicine.

[428] P. Petersen. Thromboembolic complications in atrial fibrillation. , 1990, Stroke.

[429] M. Blombäck,et al. Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. , 1990, Stroke.

[430] I. V. Van Gelder,et al. Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. , 1989, The American journal of cardiology.

[431] E. Pritchett,et al. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group. , 1989, Circulation.

[432] A. Adgey,et al. Electrode pad size, transthoracic impedance and success of external ventricular defibrillation. , 1989, The American journal of cardiology.

[433] P. Brill-Edwards,et al. Heparin therapy during pregnancy. Risks to the fetus and mother. , 1989, Archives of internal medicine.

[434] L Goldman,et al. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. , 1989, The American journal of medicine.

[435] B. Buxton,et al. Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly? , 1989, The Journal of thoracic and cardiovascular surgery.

[436] J. Kastrup,et al. Cerebral Blood Flow before and after Cardioversion of Atrial Fibrillation , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[437] D. Warrell. CEREBRAL CONSUMPTION OF GLUCOSE - REPLY , 1989 .

[438] E. Antman,et al. Efficacy of intravenous propafenone for the acute management of atrial fibrillation. , 1989, The American journal of cardiology.

[439] E. Tuzcu,et al. The usefulness of amiodarone in management of refractory supraventricular tachyarrhythmias. , 1989, Cleveland Clinic journal of medicine.

[440] E. Michelson,et al. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. , 1989, The American journal of cardiology.

[441] S. Connolly,et al. Usefulness of propafenone for recurrent paroxysmal atrial fibrillation. , 1989, The American journal of cardiology.

[442] J. Kingma,et al. Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. , 1989, The American journal of cardiology.

[443] J. Le Heuzey,et al. [The natural history of 270 cases of Wolff-Parkinson-White syndrome in a survey of the general population]. , 1989, Archives des maladies du coeur et des vaisseaux.

[444] W. Manning,et al. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. , 1989, Journal of the American College of Cardiology.

[445] Frank J. Hildner,et al. ArticlesAntithrombotic Therapy in Atrial Fibrillation , 1989 .

[446] J. Agmon,et al. Atrial fibrillation. Cause and time of onset. , 1989, Archives of internal medicine.

[447] R. Bryg,et al. Effect of pregnancy on pressure gradient in mitral stenosis. , 1989, The American journal of cardiology.

[448] Palle Petersen,et al. PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.

[449] Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group. , 1989 .

[450] J. McMurray,et al. Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. , 1989, Journal of cardiovascular pharmacology.

[451] Flecainide versus quinidine in the prevention of paroxysms of atrial fibrillation. , 1989, Journal of cardiovascular pharmacology.

[452] J. Porterfield,et al. Therapeutic efficacy and safety of oral propafenone for atrial fibrillation. , 1989, The American journal of cardiology.

[453] I. V. Van Gelder,et al. Effects of flecainide on the atrial defibrillation threshold. , 1989, The American journal of cardiology.

[454] S. Sandhu,et al. Optimal sampling interval to estimate heart rate at rest and during exercise in atrial fibrillation. , 1989, The American journal of cardiology.

[455] L. Rydén,et al. Long-term efficacy of flecainide in paroxysmal atrial fibrillation. , 2009, Acta medica Scandinavica.

[456] L. Rydén,et al. Chronic atrial fibrillation. Long-term results of direct current conversion. , 2009 .

[457] H. Crijns,et al. Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment. , 1988, The American journal of cardiology.

[458] Daniel E. Singer,et al. Stroke Following Coronary-Artery Bypass Surgery , 1988 .

[459] J Nyboe,et al. Stroke incidence and risk factors for stroke in Copenhagen, Denmark. , 1988, Stroke.

[460] E. Antman,et al. Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter. , 1988, Journal of the American College of Cardiology.

[461] C. Foster,et al. Amiodarone in pregnancy. Case report and review of the literature. , 1988, International journal of cardiology.

[462] E. Aliot,et al. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. , 1988, Progress in cardiovascular diseases.

[463] S. Lévy,et al. High energy transcatheter cardioversion of chronic atrial fibrillation. , 1988, Journal of the American College of Cardiology.

[464] J. Halperin,et al. Atrial fibrillation and stroke: new ideas, persisting dilemmas. , 1988, Stroke.

[465] P. Gates,et al. Asymptomatic cerebral infarction in patients with chronic atrial fibrillation. , 1988, Stroke.

[466] S. Goldstein,et al. Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. , 1988, Chest.

[467] W. Daniel,et al. Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. , 1988, Journal of the American College of Cardiology.

[468] W. Mckenna,et al. Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinus rhythm. , 1988, British heart journal.

[469] J B Martins,et al. Energy, current, and success in defibrillation and cardioversion: clinical studies using an automated impedance-based method of energy adjustment. , 1988, Circulation.

[470] G. Klein,et al. Propafenone for prevention of recurrent atrial fibrillation. , 1988, The American journal of cardiology.

[471] F L Meijler,et al. Effect of right ventricular pacing on ventricular rhythm during atrial fibrillation. , 1988, Journal of the American College of Cardiology.

[472] L. E. Peterson,et al. Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study. , 1988, European heart journal.

[473] B. Gersh,et al. Propafenone for paroxysmal atrial fibrillation. , 1988, The American journal of cardiology.

[474] M. Allessie,et al. Length of Excitation Wave and Susceptibility to Reentrant Atrial Arrhythmias in Normal Conscious Dogs , 1988, Circulation research.

[475] R. Zimmerman,et al. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. , 1988, Circulation research.

[476] Hemodynamic Consequences of Cardiac Arrhythmias , 1988 .

[477] D. Singer,et al. Stroke following coronary-artery bypass surgery. A case-control estimate of the risk from carotid bruits. , 1988, The New England journal of medicine.

[478] P. Petersen,et al. Stroke in thyrotoxicosis with atrial fibrillation. , 1988, Stroke.

[479] P. Brugada,et al. Reversibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable atrial fibrillation. , 1987, The American journal of cardiology.

[480] C. Gyldensted,et al. Silent cerebral infarction in chronic atrial fibrillation. , 1987, Stroke.

[481] G. Taylor,et al. Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting. , 1987, The American journal of cardiology.

[482] B. Gersh,et al. The natural history of lone atrial fibrillation. A population-based study over three decades. , 1987, The New England journal of medicine.

[483] P. Wolf,et al. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. , 1987, Archives of internal medicine.

[484] M. Brodsky,et al. Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium. , 1987, The American journal of cardiology.

[485] M. Rubenfire,et al. Amiodarone in the management of refractory atrial fibrillation. , 1987, Archives of internal medicine.

[486] T. Ives,et al. Mexiletine use in pregnancy and lactation. , 1987, American journal of obstetrics and gynecology.

[487] R. Falk,et al. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial. , 1987, Annals of internal medicine.

[488] G. Rose,et al. RISK OF STROKE IN NON-RHEUMATIC ATRIAL FIBRILLATION , 1987, The Lancet.

[489] Precipitation of cardiac arrest by verapamil in patients with Wolff-Parkinson-White syndrome. , 1987, Annals of internal medicine.

[490] E. Salazar,et al. Risks of anticoagulant therapy in pregnant women with artificial heart valves. , 1986, The New England journal of medicine.

[491] J. Goy,et al. Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm. , 1986, The American journal of cardiology.

[492] J. Landry,et al. Factors predisposing to supraventricular tachyarrhythmias after coronary artery bypass grafting. , 1986, The American journal of cardiology.

[493] J. Ruskin,et al. Precipitation of Cardiac Arrest by Verapamil in Patients with Wolff-ParkinsonWhite Syndrome , 1986 .

[494] R. Coleman,et al. Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. , 1986, The American journal of cardiology.

[495] M. Schlüter,et al. Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombus. , 1986, Journal of the American College of Cardiology.

[496] J. Alpert,et al. Amiodarone for refractory atrial fibrillation. , 1986, The American journal of cardiology.

[497] P. Wolf,et al. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. , 1985, JAMA.

[498] L. Horowitz,et al. Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy. , 1985, Journal of the American College of Cardiology.

[499] T. Bateman,et al. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias. , 1985, Journal of the American College of Cardiology.

[500] J. Neutze,et al. Arrhythmia prophylaxis after aorta-coronary bypass. The effect of minidose propranolol. , 1985, The Journal of thoracic and cardiovascular surgery.

[501] R. Zupkis,et al. Antiarrhythmic effects of intravenous timolol in supraventricular arrhythmias , 1985, Clinical pharmacology and therapeutics.

[502] M. Allessie,et al. Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation , 1985 .

[503] P. Genton,et al. Effects of propranolol and of verapamil on heart rate and blood pressure in hyperthyroidism , 1984, Clinical pharmacology and therapeutics.

[504] E. Williams. A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs , 1984 .

[505] T. Agner,et al. A reevaluation of atrial fibrillation in thyrotoxicosis. , 1984, Danish medical bulletin.

[506] B. Gersh,et al. The efficacy of quinidine and disopyramide in the maintenance of sinus rhythm after electroconversion from atrial fibrillation. A double-blind study comparing quinidine, disopyramide and placebo. , 1984, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[507] Patton Jn,et al. The effects of shock energy, propranolol, and verapamil on cardiac damage caused by transthoracic countershock. , 1984 .

[508] E. V. Vaughan Williams. A classification of antiarrhythmic actions reassessed after a decade of new drugs. , 1984, Journal of clinical pharmacology.

[509] J. Pantridge,et al. The effects of shock energy, propranolol, and verapamil on cardiac damage caused by transthoracic countershock. , 1984, Circulation.

[510] W. Kannel,et al. Coronary heart disease and atrial fibrillation: the Framingham Study. , 1983, American heart journal.

[511] E. Michelson,et al. The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. , 1983, American heart journal.

[512] G. Klein,et al. Ventricular fibrillation following verapamil in the Wolff-Parkinson-White syndrome. , 1983, American heart journal.

[513] D. Holt,et al. AMIODARONE IN PREGNANCY , 1983, The Lancet.

[514] T. Meinertz,et al. Prevalence of Arrhythmias During 24-Hour Electrocardiographic Monitoring in Patients with Dilative Cardiomyopathy , 1983 .

[515] F. Cosío,et al. Electrophysiologic studies in atrial fibrillation , 1983 .

[516] F. Cosío,et al. Electrophysiologic studies in atrial fibrillation. Slow conduction of premature impulses: a possible manifestation of the background for reentry. , 1983, The American journal of cardiology.

[517] E. Michelson,et al. Atrioventricular nodal conduction during atrial fibrillation in rabbit heart. , 1982, The American journal of physiology.

[518] J. Hobbins,et al. Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease , 1982 .

[519] A. Goldberger,et al. Cardioversion of atrial fibrillation: consideration of embolization, anticoagulation, prophylactic pacemaker, and long-term success. , 1982, American heart journal.

[520] R. Kerber,et al. The Effects of Atrial Fibrillation on Atrial Pressure‐ Volume and Flow Relationships , 1982, Circulation research.

[521] K. Ito,et al. Management of atrial fibrillation in the post-thyrotoxic state. , 1982, The American journal of medicine.

[522] R. Prescott,et al. CONTROLLED TRIAL OF SOTALOL FOR ONE YEAR AFTER MYOCARDIAL INFARCTION , 1982, The Lancet.

[523] W. Kannel,et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. , 1982, The New England journal of medicine.

[524] [Atrial arrhythmias of vagal or catecholaminergic origin: comparative effects of beta-blocker treatment and the escape phenomenon]. , 1982, Archives des maladies du coeur et des vaisseaux.

[525] K. Rasmussen,et al. Comparative efficiency of quinidine and verapamil in the maintenance of sinus rhythm after DC conversion of atrial fibrillation. A controlled clinical trial. , 2009, Acta medica Scandinavica. Supplementum.

[526] D. W. Cheung. Pulmonary vein as an ectopic focus in digitalis-induced arrhythmia , 1981, Nature.

[527] J. Karliner,et al. Safety of electrical cardioversion in patients without digitalis toxicity. , 1981, Annals of internal medicine.

[528] R. Kerber,et al. Elective cardioversion: influence of paddle-electrode location and size on success rates and energy requirements. , 1981, The New England journal of medicine.

[529] M. Ehrenfeld,et al. Arterial embolism in thyrotoxicosis with atrial fibrillation. , 1981, Archives of internal medicine.

[530] W. Mckenna,et al. Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis. , 1981, British heart journal.

[531] J. Stockigt,et al. Atrial fibrillation and arterial embolism in hyperthyroidism. , 1981, Australian and New Zealand journal of medicine.

[532] F. Dunn,et al. Echocardiographic diastolic ventricular abnormality in hypertensive heart disease: atrial emptying index. , 1981, The American journal of cardiology.

[533] D. W. Cheung. Electrical activity of the pulmonary vein and its interaction with the right atrium in the guinea‐pig. , 1981, The Journal of physiology.

[534] J. Delahaye,et al. Controlled trial of a long-acting quinidine for maintenance of sinus rhythm after conversion of sustained atrial fibrillation. , 1981, European heart journal.

[535] E. Vitolo,et al. Amiodarone versus quinidine in the prophylaxis of atrial fibrillation. , 1981, Acta cardiologica.

[536] M. Hennersdorf,et al. The Heart in Hypertension , 1981, International Boehringer Mannheim Symposia.

[537] C. Robertson,et al. Extreme tachycardia complicating the use of disopyramide in atrial flutter. , 1980, British heart journal.

[538] R. Crampton,et al. Accepted, controversial, and speculative aspects of ventricular defibrillation. , 1980, Progress in cardiovascular diseases.

[539] E. Prystowsky,et al. Effects of Intravenous and Chronic Oral Verapamil Administration in Patients with Supraventricular Tachyarrhythmias , 1980, Circulation.

[540] R. Stevenson,et al. Hazards of oral anticoagulants during pregnancy. , 1980, JAMA.

[541] A L Waldo,et al. Characterization of Atrial Flutter: Studies in Man After Open Heart Surgery Using Fixed Atrial Electrodes , 1979, Circulation.

[542] A. Toft,et al. Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation. , 1979, The American journal of cardiology.

[543] P. Thompson,et al. EMBOLISM IN THYROTOXIC ATRIAL FIBRILLATION , 1979, The Medical journal of Australia.

[544] B. Maron,et al. Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. , 1979, Circulation.

[545] J. Staffurth,et al. Arterial embolism in thyrotoxicosis with atrial fibrillation. , 1977, British medical journal.

[546] G A Ewy,et al. Effects of electrical countershock on serum creatine phosphokinase (CPK) isoenzyme activity. , 1976, The American journal of cardiology.

[547] G. Rosenhamer,et al. Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm. , 1975, British heart journal.

[548] G. Böhm,et al. The cardiac muscle in the pulmonary vein of the rat: A morphological and electrophysiological study , 1975 .

[549] O. Paes de Almeida,et al. The cardiac muscle in the pulmonary vein of the rat: a morphological and electrophysiological study. , 1975, Journal of morphology.

[550] G A Ewy,et al. Myocardial Necrosis from Direct Current Countershock: Effect of Paddle Electrode Size and Time Interval Between Discharges , 1974, Circulation.

[551] A. Louhija,et al. Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion , 1974, Clinical pharmacology and therapeutics.

[552] Z. J. Lipowski. Letter: Psychosomatic medicine. , 1974, Lancet.

[553] T. Petty,et al. Arrhythmias associated with acute respiratory failure in patients with chronic airway obstruction. , 1973, Chest.

[554] G. Ewy,et al. Transthoracic impedance to defibrillator discharge. Effect of electrode size and electrode-chest wall interface. , 1973, Journal of electrocardiology.

[555] R. Barr,et al. Spread of excitation from the atrium into thoracic veins in human beings and dogs. , 1972, The American journal of cardiology.

[556] D. Zipes,et al. Electrical properties of the thoracic veins. , 1972, The American journal of cardiology.

[557] S. Olsson,et al. Monophasic action potential and sinus rhythm stability after conversion of atrial fibrillation. , 2009, Acta medica Scandinavica.

[558] J. Dale,et al. Quinidine in maintenance of sinus rhythm after electroconversion of chronic atrial fibrillation. A controlled clinical study. , 1971, British heart journal.

[559] L McDonald,et al. Electroversion of lone atrial fibrillation and flutter including haemodynamic studies at rest and on exercise. , 1971, British heart journal.

[560] L. Dreifus,et al. Ventricular Fibrillation: A Possible Mechanism of Sudden Death in Patients with Wolff‐Parkinson‐White Syndrome , 1971, Circulation.

[561] A. Kristinsson,et al. Long-term follow-up of direct current cardioversion after cardiac surgery with special reference to quinidine1 , 1970, British heart journal.

[562] A. Wing,et al. Maintenance of sinus rhythm after DC reversion of atrial fibrilllation. A double-blind controlled trial of long-acting quinidine bisulphate. , 1970, British heart journal.

[563] A. Louhija,et al. Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation. , 1970, British heart journal.

[564] E. Flensted-Jensen. Wolff-Parkinson-White syndrome. A long-term follow-up of 47 cases. , 2009 .

[565] O. Orning,et al. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. , 1969, The American journal of cardiology.

[566] H. Åberg,et al. Direct current countershock complications. , 2009, Acta medica Scandinavica.

[567] D. Evans,et al. Long-term results of DC reversion of atrial fibrillation. , 1968, British heart journal.

[568] D. Wood,et al. Factors affecting cardioversion of atrial arrhythmias with special reference to quinidine. , 1968, British heart journal.

[569] G. Cramér. Early and late results of conversion of atrial fibrillation with quinidine. A clinical and hemodynamic study. , 1968, Acta medica Scandinavica. Supplementum.

[570] B. Lown,et al. The use of quinidine in cardioversion. , 1967, The American journal of cardiology.

[571] H. Nathan,et al. The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts. , 1966, Circulation.

[572] B. Lown,et al. Cardioversion and Digitalis Drugs: Changed Threshold to Electric Shock in Digitalized Animals , 1965, Circulation research.

[573] R. Langendorf,et al. Ventricular Response in Atrial Fibrillation: Role of Concealed Conduction in the AV Junction , 1965, Circulation.

[574] F. Epstein,et al. Electrocardiographic Findings Among the Adult Population of a Total Natural Community, Tecumseh, Michigan , 1965, Circulation.

[575] T. Walsh,et al. WOLFF-PARKINSON-WHITE SYNDROME. , 1965, American heart journal.

[576] L. Dreifus,et al. COMPLICATIONS AND LIMITATIONS OF DIRECT-CURRENT COUNTERSHOCK. , 1964, JAMA.

[577] J. .. Abildskov,et al. Observations on the Ventricular Dysrhythmia Associated with Atrial Fibrillation in the Dog Heart , 1964, Circulation research.

[578] B. Lown,et al. "Cardioversion" of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients. , 1963, The New England journal of medicine.

[579] B. Lown,et al. New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge. , 1986, JAMA.

[580] J A ABILDSKOV,et al. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. , 1959, American heart journal.

[581] F. London,et al. Atrial flutter: 1 to 1 conduction during treatment with quinidine and digitalis. , 1954, American heart journal.

[582] W. Evans,et al. LONE AURICULAR FIBRILLATION , 1954, British heart journal.

[583] D. Scherf,et al. Mechanism of flutter and fibrillation. , 1953, Bulletin. New England Medical Center.

[584] S. A. Levine,et al. Auricular fibrillation without other evidence of heart disease; a cause of reversible heart failure. , 1949, The American journal of medicine.

[585] D. Scherf,et al. Experimental studies on auricular flutter and auricular fibrillation. , 1948, American heart journal.

[586] R. Ashman,et al. Auricular fibrillation with aberration simulating ventricular paroxysmal tachycardia. , 1947, American heart journal.

[587] S. Bellet,et al. Clinical disorders of the heart beat. , 1946, Clinics.

[588] J. Gunning,et al. Long-term follow-up of direct current cardioversion after cardiac surgery with special reference to quinidine ' , 2022 .